Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

RowdMap Health Datapalooza Payer Provider Risk Readiness

1,094 views

Published on

Presentation from a super duper special event at Health Datapalooza with Bryant Hutson and Ashley Distler, Senior Client Strategists at RowdMap.

Has Open Health Data produced any successful new companies?

Come see a company founded on open health data that has taken the market by storm.

RowdMap, an Ernst and Young EY Entrepreneur of the Year® winner works with payers and providers in 48 States covering 100MM Americans.


Is Open Data just for consumer apps or traditional B2B problems?

Come see open health data used by payers and providers to move from FFS to value based care.

30 Cents of every dollar spent goes to care that doesn’t produce improved outcomes based in FFS. RowdMap identifies and quantifies low value care for virtually every provider the country, then works with payers and providers to reduce it through value based care.

One of our country’s most significant challenges is the 30 cents of every dollar to goes to low-value care, or care that doesn’t produce any better outcomes than lower-cost, lower risk alternatives. Low value care accounts for $850BB a year or 3% of GDP and historically has been driven by Fee for Service billing.

The promise of data liberation was for new businesses to solve major challenges, and, while there’s been plenty of aspiration and hype, after seven years, meaningful success stories are few and far between.

One notable exception is RowdMap, Inc., an Ernst and Young EY Entrepreneur Of The Year® winner, that uses public HHS data to help providers and payers reduce low value care.

RowdMap’s clients use HHS data to move from FFS in 48 states, covering 102MM patients and members across provider organizations of all types and payers in exchange/marketplace, commercial, Medicare, Medicaid. RowdMap’s clients includes payers in all lines of business (Marketplace / Exchange, Commercial, Medicare Advantage and Medicaid) and providers in all shapes and sizes (Clinically Integrated Networks, Primary Care Provider Groups, Speciality Provider Groups, Accountable Care Organizations). RowdMap is also the official partner of US News and World Report, publisher of Best Doctors and Best Hospitals.

Published in: Health & Medicine
  • Be the first to comment

RowdMap Health Datapalooza Payer Provider Risk Readiness

  1. 1. All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. Hi, We’re Ashley & Bryant
  2. 2. 2 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. HEALTH DATAPALOOZA Summary Learn more about how both payers and providers are using HHS data to identify, quantify and reduce low-value services as they move from Fee for Service to Pay for Value arrangements. RowdMap’s Risk-Readiness® benchmarks help health plans, physician groups, and hospital systems identify, quantify, and reduce delivery of no-value care—a central tenet of successful pay-for-value programs. RowdMap uses public data including Part B, D and A and referrals as well as BRFSS and other CDC data, viewed in light of the Dartmouth Atlas for Unwarranted Variation to determine which geographies and providers will likely succeed in the movement from Fee for Service to Pay for Value and Risk Arrangements. RowdMap is using HHS data with clients in 48 states and the District of Columbia covering over 100MM members and patients, with Payers across all lines of business including MA, Medicaid, Exchange/Marketplace, Large Group & Small Group populations and with Providers including Specialty Groups, PCP groups, CINs, ACOs and Hospital-based systems. Payers let RowdMap help them use HHS data to move to value based arrangements by building and optimizing networks then growing through the best providers; Providers let RowdMap help them use HHS data to calculate their real impact of their practice patterns for whoever owns the risk, using a different approach than traditional utilization or actuarial unit cost analysis. Providers then pick value-based programs, negotiate with Payers, and make changes to individual providers and their delivery to succeed in the shift from FFS to Risk. For helping both Payers and Providers in health care market use HHS data to move from Fee for Service to Pay for Value arrangements, RowdMap has been named Ernst and Young EY Entrepreneurs of the Year®. RowdMap has also partnered with US NEWS to help consumers make more informed decisions and avoid low value services by using HHS data.
  3. 3. 3 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. HEALTH DATAPALOOZA What We’re Not Interested in Learn more about how both payers and providers are using HHS data to identify, quantify and reduce low-value services as they move from Fee for Service to Pay for Value arrangements. Not advocating for policy/programsNot selling you anything Not exploiting models/mechanics for short term gain Bundle-O-MaticACOs-R’-USData/Claim Systems
  4. 4. 4 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. HEALTH DATAPALOOZA What We Are Interested in Learn more about how both payers and providers are using HHS data to identify, quantify and reduce low-value services as they move from Fee for Service to Pay for Value arrangements. Want to share where your data is being used by payers and providers to move out of FFS and take on shared risk, sometimes working together with HHS data as common basis for partnerships and shared risk arrangements. Used to design networks, change practice patterns and manage care, select government programs or risk arrangements, pick partners and negotiate risk, design financially viable products and as evaluate criteria to for success value based arrangements. Want to share your data holds up extends to providers and payers in marketplace/exchange, commercial large/small group, etc. Want to advocate for continued data releases. Basically, encourage HHS & the market to keep rocking the mike!
  5. 5. 5 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. HEALTH DATAPALOOZA Who Uses HHS Data for Real Strategy & Ops? Learn more about how both payers and providers are using HHS data to identify, quantify and reduce low-value services as they move from Fee for Service to Pay for Value arrangements. Health plans and providers in 48 states and the District of Columbia use RowdMap and HHS data to reduce the delivery of no-value care. The clients RowdMap serves collectively cover the lives of more than 100 million Americans. Here’s where HHS Data is being used to move from FFS to Value Base Arrangements (not ‘pilot’ or ‘innovation’ programs) but active operational programs. Clients using HHS data include National, Regional & Boutique Payers in Marketplace/Exchange, MA, Medicaid, Commercial and Government Programs as well as Providers including PCP & Specialty Groups, CINs & Systems, ACOs, Bundles & other CMMI Program Participants.
  6. 6. 6 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. HEALTH DATAPALOOZA Low-Value Services: Why You Should Give a Darn RowdMap’s Risk-Readiness® benchmarks help health plans, physician groups, and hospital systems identify, quantify, and reduce delivery of no-value care—a central tenet of successful pay-for-value programs. Over $9B in Orange County, CA $850 Billion Unnecessary Spend in 2014 (Institute of Medicine) Institute of Medicine (IOM) report, “Best Care at Lower Cost,” (Sept. 2012) estimates that the United States lost $750 billion in 2012. (Adjusted in 2013 at $800BB, 2014 at $850BB.) This is about 3% of GDP. No-Value Care (30%) Necessary Utilization (70%) “It’s generally agreed that about 30 percent of what we spend on health care is unnecessary. If we eliminate the unneeded care, there are more than enough resources in our system to cover everybody.” -Dr. Elliott Fisher, Dartmouth Institute for Health Policy “Bigger than higher prices, administrative expenses, and fraud, however, was the amount spent on unnecessary health-care services.” In just a single year, up to 42% of patients receive “No Value” Care. - Dr. Atul Gawande, Department of Health Policy and Management at the Harvard School of Public Health & Department of Surgery at Harvard Medical School
  7. 7. 7 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. HEALTH DATAPALOOZA Low-Value Services: Broad, Increasing Interest RowdMap’s Risk-Readiness® benchmarks help health plans, physician groups, and hospital systems identify, quantify, and reduce delivery of no-value care—a central tenet of successful pay-for-value programs. Research Evaluating CMS & Private Plan Programs: “Do they reduce Low Value care?” Popular Press Reporting and Provider Rankings: “Consumers are/should avoid Low value care.” Critique of Fee for Service: “FFS has too much Low Value care.” RowdMap partner Recommended evaluation criteria for value based plans from payers/providers
  8. 8. 8 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. HEALTH DATAPALOOZA Low Value Services: Payment Model-Driven RowdMap’s Risk-Readiness® benchmarks help health plans, physician groups, and hospital systems identify, quantify, and reduce delivery of no-value care—a central tenet of successful pay-for-value programs. Asking a different question: We’re not trying to change provider behavior, but rather create a virtuous economic cycle where docs who mitigate low-value services get paid more and pull in more patients / members Okay, explain what we’re trying to do
  9. 9. 9 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. HEALTH DATAPALOOZA Low Value Services: Practice Variation RowdMap’s Risk-Readiness® benchmarks help health plans, physician groups, and hospital systems identify, quantify, and reduce delivery of no-value care—a central tenet of successful pay-for-value programs. The estimated 30% of medical expense that goes to no-value care. Unnecessary spending drives billing in a fee-for-serve economic model, but success in pay-for-value comes from managing and mitigating these pockets of variation. Variation: Unwarranted or Unexplained? Every physician has a unique fingerprint Economic Drill Down: Example Utilization Review and Actuarial Unit Cost Analysis against Care Intensity Curve across Total Basket of Care Variation across geographies and within practices across physicians. “Physician-Level Practice Variation: Who You See Is What You Get” Brian Powers, Sachin Jain, David Cutler, & Ziad Obermeyer Health Affairs, 09.23.15 Definitions, research and geocoding by Hospital Referral Regional available via the Dartmouth Atlas for Unwarranted Variation: www.dartmouthatlas.org NB: Unwarranted variation refers to practice patterns, which hold up across populations but pricing variation may also be unwarranted and marked fluctuates across insurance product and lines and geography. “The Price Ain’t Right.” Cooper, Craig, Gaynor and Van Reenen, 2015.
  10. 10. 10 HEALTH DATAPALOOZA RowdMap’s Risk-Readiness® Benchmarks RowdMap’s Risk-Readiness® benchmarks help health plans, physician groups, and hospital systems identify, quantify, and reduce delivery of no-value care—a central tenet of successful pay-for-value programs. Providers in a Market Groups Individual Physicians What is driving a provider’s Risk-Readiness®? Is it procedures, prescriptions, referrals or visits? How big is a provider’s panel? How ready is a provider to succeed in risk compared to peers? By specialty? Within a region? Finger print with practice patterns that mitigate no-value care = Green Dot Finger print with practice patterns that create no-value care = Red Dot Risk-Readiness® Benchmarks
  11. 11. 11 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. HEALTH DATAPALOOZA Data Sources & Uses RowdMap uses public data including Part B, D and A and referrals as well as BRFSS and other CDC data, viewed in light of the Dartmouth Atlas for Unwarranted Variation to determine which geographies and providers will likely succeed in the movement from Fee for Service to Pay for Value and Risk Arrangements. Happy to go through deep methods in alternative format; essentially we’re taking a different approach. Rather than a typical diagnosis/risk/spend association model, we’re following a population-based, top-down approach to hot spot and drill into unexplained variation, then attempt to explain it through financial/contracting and clinical/population drivers. In specific cases, we do run client claims data and have their financials (MLR, actual profitability, provider contracts, etc.) but to validate/calibrate benchmarks and to “explain” the variation. We are not grouping episodic treatments to see what spending belongs which event, nor are we looking at individual patients with a bottom up total cost of care model, but rather we are taking a population-based approach, comparing practice patterns across procedures, prescriptions, visits and grouping physicians with similar profiles and asking how to they spend their time and on what compared to their peers within a region. We essentially bin providers using the HHS benchmarks then adjust and measure them in different ways, sometimes with a client’s particular methodology. Sometimes profiling the same providers from two separate vantage points, on behalf of a payer and a provider within the same market, or a PCP groups and specialty group in the same market. In other words, we are looking at ratios around unexplained variation and within an episode or across a total basket/ bundle of care is there too much/little low-value service given the patterns. For instance, is there too little pain management give the volume and intensity of specific surgeries, which leads to excess readmissions. Sometime the variation is unwarranted; sometimes it is explained via financials and contract incentives.
  12. 12. 12 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. HEALTH DATAPALOOZA Data Sources & Uses RowdMap uses public data including Part B, D and A and referrals as well as BRFSS and other CDC data, viewed in light of the Dartmouth Atlas for Unwarranted Variation to determine which geographies and providers will likely succeed in the movement from Fee for Service to Pay for Value and Risk Arrangements. Medicare DocGraph Referral file (Patient flows between PCPS, specialists, hospitals and post acute centers) Dartmouth Atlas of Health Care & Choosing Wisely (Decades of research and data on unwarranted variation by condition and geography to keep things apples-to-apples for comparisons) CMS FFS Data Sets, CDC Data Sets (MEDPAR, Part B, Part D, BRFSS) (Individual providers, groups, hospitals and post acute centers) Provider Pattern Intensity Profiles and Risk Readiness for every provider, hospital, post acute center in the US. All preloaded with no IT. Affordable Care Act data to determine Risk-Readiness of Providers / Networks
  13. 13. 13 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. HEALTH DATAPALOOZA Data Sources & Uses RowdMap uses public data including Part B, D and A and referrals as well as BRFSS and other CDC data, viewed in light of the Dartmouth Atlas for Unwarranted Variation to determine which geographies and providers will likely succeed in the movement from Fee for Service to Pay for Value and Risk Arrangements. Behaviors –Broader Definitions of Health with Behaviors Utilization – Utilization and Costs of Procedures and Drugs Prevalence – Major Diseases and Conditions Supply – Number of Primary Care Physicians and Specialists Socio-demographics –Income, Environment, etc. BRFSS etc. to minimize observation intensity bias (HCCs) and match strategies to a population to succeed in value-based programs David Wennberg, MD RowdMap Advisory Board
  14. 14. 14 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. HEALTH DATAPALOOZA Data Sources & Uses RowdMap uses public data including Part B, D and A and referrals as well as BRFSS and other CDC data, viewed in light of the Dartmouth Atlas for Unwarranted Variation to determine which geographies and providers will likely succeed in the movement from Fee for Service to Pay for Value and Risk Arrangements. Over / Under Coding County & Zip Code Under Coding Over Coding Under-coding Jacksonville Overs-coding Miami Health Factors Average Risk Scores Watch a 2 minute video on the method & concept: www.bmj.com/content/348/bmj.g2392
  15. 15. 15 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. HEALTH DATAPALOOZA Market Adoption RowdMap is using HHS data with clients in 48 states and the District of Columbia covering over 100MM members and patients, with Payers across all lines of business including MA, Medicaid, Exchange / Marketplace, Large Group & Small Group populations and with Providers including Specialty Groups, PCP groups, CINs, ACOs and Hospital-based systems. Facilitating structured conversation between payers and providers to take on shared risk using HHS benchmark data as a common foundation. Goal is virtuous cycle of best docs getting paid more with more members (30 cents per $ allows much more to play with). Removes contention as at the end of the day if the parties don’t agree, they can write risk contracts to address any issues of disagreement. Summary of Adoption:
  16. 16. 16 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. HEALTH DATAPALOOZA Market Examples – Compensating Providers Payers let RowdMap help them use HHS data to move to value based arrangements by building and optimizing networks then growing through the best providers; Providers let RowdMap help them use HHS data to calculate their real impact of their practice patterns for whoever owns the risk, using a different approach than traditional utilization or actuarial unit cost analysis. Providers then pick value- based programs, negotiate with Payers, and make changes to individual providers and their delivery to succeed in the shift from FFS to Risk.
  17. 17. 17 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. HEALTH DATAPALOOZA Market Examples – Network Optimization Payers let RowdMap help them use HHS data to move to value based arrangements by building and optimizing networks then growing through the best providers; Providers let RowdMap help them use HHS data to calculate their real impact of their practice patterns for whoever owns the risk, using a different approach than traditional utilization or actuarial unit cost analysis. Providers then pick value- based programs, negotiate with Payers, and make changes to individual providers and their delivery to succeed in the shift from FFS to Risk.
  18. 18. 18 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. HEALTH DATAPALOOZA Market Examples – Value-Based Care Chains Payers let RowdMap help them use HHS data to move to value based arrangements by building and optimizing networks then growing through the best providers; Providers let RowdMap help them use HHS data to calculate their real impact of their practice patterns for whoever owns the risk, using a different approach than traditional utilization or actuarial unit cost analysis. Providers then pick value- based programs, negotiate with Payers, and make changes to individual providers and their delivery to succeed in the shift from FFS to Risk.
  19. 19. 19 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. HEALTH DATAPALOOZA Market Examples – Virtuous Growth Cycle Payers let RowdMap help them use HHS data to move to value based arrangements by building and optimizing networks then growing through the best providers; Providers let RowdMap help them use HHS data to calculate their real impact of their practice patterns for whoever owns the risk, using a different approach than traditional utilization or actuarial unit cost analysis. Providers then pick value- based programs, negotiate with Payers, and make changes to individual providers and their delivery to succeed in the shift from FFS to Risk.
  20. 20. 20 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. HEALTH DATAPALOOZA Market Examples – Ensure Financial Viability Payers let RowdMap help them use HHS data to move to value based arrangements by building and optimizing networks then growing through the best providers; Providers let RowdMap help them use HHS data to calculate their real impact of their practice patterns for whoever owns the risk, using a different approach than traditional utilization or actuarial unit cost analysis. Providers then pick value- based programs, negotiate with Payers, and make changes to individual providers and their delivery to succeed in the shift from FFS to Risk.
  21. 21. 21 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. HEALTH DATAPALOOZA Market Examples – Design Profitable Products Payers let RowdMap help them use HHS data to move to value based arrangements by building and optimizing networks then growing through the best providers; Providers let RowdMap help them use HHS data to calculate their real impact of their practice patterns for whoever owns the risk, using a different approach than traditional utilization or actuarial unit cost analysis. Providers then pick value- based programs, negotiate with Payers, and make changes to individual providers and their delivery to succeed in the shift from FFS to Risk.
  22. 22. 22 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. HEALTH DATAPALOOZA Market Examples – Achieve Financial Viability Payers let RowdMap help them use HHS data to move to value based arrangements by building and optimizing networks then growing through the best providers; Providers let RowdMap help them use HHS data to calculate their real impact of their practice patterns for whoever owns the risk, using a different approach than traditional utilization or actuarial unit cost analysis. Providers then pick value- based programs, negotiate with Payers, and make changes to individual providers and their delivery to succeed in the shift from FFS to Risk.
  23. 23. 23 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. HEALTH DATAPALOOZA You Rock For helping both Payers and Providers in health care market use HHS data to move from Fee for Service to Pay for Value arrangements, RowdMap has been named Ernst and Young EY Entrepreneurs of the Year®. RowdMap has also partnered with US NEWS to help consumers make more informed decisions and avoid low value services by using HHS data. This is a win from establishment outside healthcare recognizing the power of HHS data to positively transform the market & economy This is consumers demanding to make informed decisions using HHS data and providers internalizing impact This is start ups making real impact and traditional market powers adopting HHS data to move from FFS to Pay for Value
  24. 24. 24 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. HEALTH DATAPALOOZA You Rock For helping both Payers and Providers in health care market use HHS data to move from Fee for Service to Pay for Value arrangements, RowdMap has been named Ernst and Young EY Entrepreneurs of the Year®. RowdMap has also partnered with US NEWS to help consumers make more informed decisions and avoid low value services by using HHS data. Told ‘ya Market Incentive Open Data Positive Disruption in a Complex System
  25. 25. 25 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. No-Value Care (30%) Necessary Utilization (70%) Care That Doesn’t Produce Better Outcomes $850 Billion Unnecessary Spend in 2014 (Institute of Medicine) No-Value Care: .30 / Each $ Is Wasted Low Value Care Drives Billing in Fee for Service “#1 Weakness of FFS Payment System Is Excess Use of Low Value Services” Dr. Patrick Conway, Chief Medical Officer, CMS
  26. 26. All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. No-Value Care: CMS Is Paying on It 2016 World Economic Forum Annual Meeting in Switzerland On track to sunset 50% of FFS
  27. 27. All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. “Millions of people are receiving drugs that aren’t helping them, operations that aren’t going to make them better, and scans and tests that do nothing beneficial for them, and often cause harm.” Dr. Atul Gawande, Professor, Department of Health Policy and Management at the Harvard School of Public Health & the Department of Surgery at Harvard Medical School. No-Value Care: Media Is Reporting on It
  28. 28. All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. "It's no secret that patients often undergo unnecessary procedures that can be dangerous and costly." Through our collaboration with RowdMap, we are providing patients with meaningful information about these no- or low-value treatments, allowing them to make better, more informed decisions about their doctors, hospitals and medical care.” No-Value Care: Consumers Demand It
  29. 29. All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. RowdMap has no-value care and population health benchmarks for… every physician every hospital every zip code …in the United States. What if you knew which providers would drive your success? No-Value Care: RowdMap Has It
  30. 30. 30 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. ABOUT ROWDMAP What We Do RowdMap’s Risk-Readiness® benchmarks help health plans, physician groups, and hospital systems identify, quantify, and reduce delivery of no-value care — a central tenet of successful pay-for-value programs.
  31. 31. 31 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. Leading the way… US CTO on RowdMap: “Visionary Genius” ABOUT ROWDMAP Market & Media Response …in the shift from fee-for service to pay-for-value. And featured in… RowdMap Partner
  32. 32. 32 All contents are proprietary to RowdMap, Inc. and are being provided on a confidential basis. Any use, reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents without the prior written consent of the Company, is prohibited. CMS: 50% of FFS will be gone by 2018 What if you knew which providers would drive your success? What if you knew which providers would sink you? WHAT WOULD YOU DO IF YOU KNEW who will win and who will lose in value based arrangements

×